Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study
- 30 April 2009
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 157 (4), 658-665
- https://doi.org/10.1016/j.ahj.2008.08.031
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Ethnic Differences in the Prognostic Value of Coronary Artery Calcification for All-Cause MortalityJournal of the American College of Cardiology, 2007
- Explaining Racial Disparities in Incidence of and Survival from Out-of-Hospital Cardiac ArrestAmerican Journal of Epidemiology, 2007
- Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA TrialJournal of the American College of Cardiology, 2007
- Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicineBMJ, 2006
- A global view of atherothrombosis: Baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialAmerican Heart Journal, 2005
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialAmerican Heart Journal, 2004
- Race and GenomicsThe New England Journal of Medicine, 2003
- Elevated Mortality Rates from Circulatory Disease in African American Men and Women of Los Angeles County, California???A Possible Genetic Susceptibility?The American Journal of the Medical Sciences, 2000
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionThe New England Journal of Medicine, 1993